Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring cyclobutane ring systems. Its functional groups enable selective modifications, making it valuable in creating complex organic molecules. Commonly employed in research settings for designing novel compounds with potential biological activity. Also utilized in the preparation of specialty chemicals where constrained ring structures enhance stability or reactivity.